Latest debt-to-equity ratio
BioLineRx Debt-to-equity ratio
Direct answer
BioLineRx's debt-to-equity ratio is 47.78%.
The verified market snapshot reports 47.78%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 2, 2026.
Get free BioLineRx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 47.78%